These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5517156)

  • 21. [Isoniazid-rifampicin: an exemplary hepatotoxicity].
    Berthelot P
    Gastroenterol Clin Biol; 1978 Feb; 2(2):129-32. PubMed ID: 640330
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
    Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rifampicin and icterus. Cases in humans].
    Graisely B; Emery JP; Hugues FC; Marche J
    Therapie; 1971; 26(4):655-69. PubMed ID: 5119120
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.
    Pessayre D; Bentata M; Degott C; Nouel O; Miguet JP; Rueff B; Benhamou JP
    Gastroenterology; 1977 Feb; 72(2):284-9. PubMed ID: 830577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 27. Jaundice associated with rifampicin.
    Hollins PJ; Simmons AV
    Tubercle; 1970 Sep; 51(3):328-32. PubMed ID: 5495656
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic dysfunction in undernourished patients receiving isoniazid and rifampicin.
    Krishnaswamy K; Prasad CE; Murthy KJ
    Trop Geogr Med; 1991; 43(1-2):156-60. PubMed ID: 1750106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatotoxicity of the rifampicin-isoniazid combination in children].
    Bonora G; De La Pierre L; Perletti L
    Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Isoniazid and the liver.
    Hanson AS
    Am Rev Respir Dis; 1974 Dec; 110(6):817. PubMed ID: 4429278
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic toxicity of antituberculous drugs in children.
    Allué X; Sanjurjo P; Fidalgo I; Bilbao F
    Helv Paediatr Acta; 1976 Dec; 31(4-5):381-7. PubMed ID: 1017983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 34. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of combined rifampicin therapy on transaminases].
    Sehm G
    Prax Pneumol; 1971 Jun; 25(6):329-38. PubMed ID: 5561148
    [No Abstract]   [Full Text] [Related]  

  • 36. [Jaundice and rifampicin].
    Piéron R; Marien C; Jagueux M
    Sem Hop; 1971 Apr; 47(20):1286-95. PubMed ID: 4326532
    [No Abstract]   [Full Text] [Related]  

  • 37. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis after isoniazid administration.
    Martin CE; Arthaud JB
    N Engl J Med; 1970 Feb; 282(8):433-4. PubMed ID: 5412191
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of rifampicin-induced acute renal failure and review of 47 cases with liver dysfunction induced by isoniazid and rifampicin (author's transl)].
    Sugiyama Y; Kudo S; Kitamura S; Kosaka K
    Kekkaku; 1981 Jul; 56(7):375-8. PubMed ID: 7328998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.